Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58,548,563
-
Total 13F shares
-
31,514,831
-
Share change
-
-1,292,528
-
Total reported value
-
$94,544,563
-
Put/Call ratio
-
90%
-
Price per share
-
$3.00
-
Number of holders
-
84
-
Value change
-
-$2,354,415
-
Number of buys
-
52
-
Number of sells
-
34
Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q2 2023
As of 30 Jun 2023 BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,514,831 shares of stock of the company.
Largest 10 holders included Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, WASATCH ADVISORS LP, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 85 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.